Zacks: Analysts Expect Teladoc Health Inc (TDOC) to Announce -$0.35 Earnings Per Share

Share on StockTwits

Equities research analysts forecast that Teladoc Health Inc (NYSE:TDOC) will report earnings of ($0.35) per share for the current fiscal quarter, according to Zacks Investment Research. Ten analysts have issued estimates for Teladoc Health’s earnings, with the lowest EPS estimate coming in at ($0.40) and the highest estimate coming in at ($0.22). Teladoc Health reported earnings per share of ($0.50) during the same quarter last year, which would indicate a positive year-over-year growth rate of 30%. The firm is expected to issue its next quarterly earnings results on Tuesday, February 26th.

On average, analysts expect that Teladoc Health will report full year earnings of ($1.47) per share for the current financial year, with EPS estimates ranging from ($1.52) to ($1.33). For the next financial year, analysts forecast that the firm will report earnings of ($1.06) per share, with EPS estimates ranging from ($1.40) to ($0.60). Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research firms that follow Teladoc Health.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Thursday, November 1st. The health services provider reported ($0.34) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.36) by $0.02. Teladoc Health had a negative net margin of 31.32% and a negative return on equity of 14.05%. The business had revenue of $111.00 million for the quarter, compared to analyst estimates of $109.94 million. During the same period in the previous year, the business posted ($0.55) earnings per share. The business’s revenue was up 61.6% compared to the same quarter last year.

A number of brokerages have recently issued reports on TDOC. Canaccord Genuity boosted their price target on shares of Teladoc Health from $86.00 to $94.00 and gave the stock a “buy” rating in a research note on Friday, September 28th. TheStreet upgraded shares of Teladoc Health from a “d+” rating to a “c” rating in a research note on Wednesday, August 22nd. Leerink Swann began coverage on shares of Teladoc Health in a research note on Thursday, August 16th. They set an “outperform” rating and a $90.00 price target on the stock. Robert W. Baird boosted their price target on shares of Teladoc Health from $65.00 to $80.00 and gave the stock a “neutral” rating in a research note on Friday, September 28th. Finally, Craig Hallum boosted their price target on shares of Teladoc Health from $70.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, October 15th. Four research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the stock. Teladoc Health presently has a consensus rating of “Buy” and a consensus target price of $85.06.

In other Teladoc Health news, CEO Jason N. Gorevic sold 25,000 shares of the company’s stock in a transaction dated Monday, September 17th. The shares were sold at an average price of $75.05, for a total value of $1,876,250.00. Following the sale, the chief executive officer now owns 536,184 shares of the company’s stock, valued at $40,240,609.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jason N. Gorevic sold 35,000 shares of the company’s stock in a transaction dated Monday, November 19th. The shares were sold at an average price of $54.80, for a total transaction of $1,918,000.00. Following the completion of the sale, the chief executive officer now directly owns 541,184 shares in the company, valued at approximately $29,656,883.20. The disclosure for this sale can be found here. Insiders have sold 255,929 shares of company stock worth $17,683,623 over the last 90 days. 3.95% of the stock is currently owned by company insiders.

Several hedge funds and other institutional investors have recently made changes to their positions in TDOC. Harvest Fund Management Co. Ltd purchased a new stake in shares of Teladoc Health in the third quarter valued at about $165,000. Signaturefd LLC purchased a new stake in shares of Teladoc Health in the third quarter valued at about $173,000. Aperio Group LLC purchased a new stake in shares of Teladoc Health in the second quarter valued at about $201,000. California Public Employees Retirement System purchased a new stake in shares of Teladoc Health in the second quarter valued at about $203,000. Finally, Biondo Investment Advisors LLC purchased a new stake in shares of Teladoc Health in the second quarter valued at about $205,000.

Shares of Teladoc Health stock traded down $2.40 on Monday, reaching $53.41. 2,297,902 shares of the stock were exchanged, compared to its average volume of 1,497,695. Teladoc Health has a 1-year low of $30.88 and a 1-year high of $89.05. The company has a quick ratio of 8.99, a current ratio of 8.99 and a debt-to-equity ratio of 0.40. The firm has a market cap of $3.91 billion, a price-to-earnings ratio of -32.37 and a beta of 0.92.

Teladoc Health Company Profile

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Further Reading: What Does Beta Mean In Stock Selection

Get a free copy of the Zacks research report on Teladoc Health (TDOC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.